FIELD: medicine, nephrourology. SUBSTANCE: method deals with treating uremia. For this purpose one should introduce gel form of finely divided chitosan either per oral or through a probe per 4 ml/kg body weight in every 3 h. The method leads to efficient detoxication at uremia of different genesis, in incurable patients in case of prolongation of predialysis terms when active methods of therapy are contraindicated, as well. EFFECT: higher efficiency of therapy. 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ENTEROSORBENT FOR TREATING RENAL INSUFFICIENCY | 1994 |
|
RU2097046C1 |
| METHOD OF PANCREATITIS DESTRUCTIVE FORM TREATMENT | 2001 |
|
RU2196587C1 |
| METHOD FOR REMOVING FUNCTIONAL DUODENOSTASIS IN CASE OF PANCREONECROSIS | 2003 |
|
RU2240802C1 |
| METHOD OF PROPHYLAXIS AND TREATMENT OF PREGNANT ANIMALS WITH TOXICOSIS | 1997 |
|
RU2136289C1 |
| METHOD OF RESTORING FUNCTIONAL KIDNEY RESERVE | 1993 |
|
RU2084248C1 |
| METHOD FOR DETERMINING UREMIC ENCEPHALOPATHY DEVELOPMENT DEGREE IN PATIENTS SUFFERING FROM CHRONIC RENAL INSUFFICIENCY | 2004 |
|
RU2272562C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH STAGE V CHRONIC KIDNEY DISEASE AT DIALYSIS STAGE | 2020 |
|
RU2753127C1 |
| AGENT FOR LOW-METABOLIC BONE DISEASE IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY | 2012 |
|
RU2485957C1 |
| ENTEROSORPTION METHOD | 1997 |
|
RU2122868C1 |
| METHOD FOR ESTABLISHING UREMIC GENESIS OF POLYNEUROPATHY | 2006 |
|
RU2314527C1 |
